Bibliography
Dettmer, P 2021, Immune, Hodder & Stoughton, London.
Divgi, C 2020, ‘Overcoming Barriers to Radiopharmaceutical Therapy (RPT): An Overview From the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy’, International journal of radiation oncology, biology, physics, vol. 109, viewed 30 July 2022, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399328/.
Elliyanti, A 2021, ‘Radiopharmaceuticals in Modern Cancer Therapy’, Radiopharmaceuticals - Current Research for Better Diagnosis and Therapy, viewed 30 July 2022, https://www.intechopen.com/chapters/78024.
Good Practice for Introducing Radiopharmaceuticals for Clinical Use 2015, International Atomic Energy Agency, pdf, viewed 30 July 2022, http://www-pub.iaea.org/MTCD/Publications/PDF/TE-1782_web.pdf.
IAEA Office of Public Information and Communication, I 2017, Radiopharmaceuticals - a key component of nuclear medicine, online video, 5 October, viewed 1 August 2022, https://www.youtube.com/watch?v=8YlABLzefKg.
Lau, J 2020, ‘Insight into the Development of PET Radiopharmaceuticals for Oncology’, Cancer, vol. 12, viewed 30 July 2022, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281377/.
National Cancer Institute 2020, Radiopharmaceuticals: Radiation Therapy Enters the Molecular Age, The US Government, viewed 30 July 2022, https://www.cancer.gov/news-events/cancer-currents-blog/2020/radiopharmaceuticals-cancer-radiation-therapy.
National Cancer Institute 2021, For Advanced Prostate Cancer, Radiopharmaceutical Improves Survival, The US Government, viewed 30 July 2022, https://www.cancer.gov/news-events/cancer-currents-blog/2021/prostate-cancer-psma-radiopharmaceutical-vision.
OUR TECHNOLOGY n.d., viewed 30 July 2022, https://telixpharma.com/our-technology/.
Sgouros, G 2019, ‘Radiopharmaceutical Therapy’, Health Phys., viewed 30 July 2022, https://pubmed.ncbi.nlm.nih.gov/30585960/.
Sgouros, G 2020, ‘Radiopharmaceutical therapy in cancer: clinical advances and challenges’, Nature Reviews Drug Discovery, 1 September, viewed 30 July 2022, https://www.nature.com/articles/s41573-020-0073-9.
Sgouros, G 2021, ‘Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns’, Journal of nuclear medicine: official publication, Society of Nuclear Medicine, vol. 62, viewed 30 July 2022, https://pubmed.ncbi.nlm.nih.gov/34857617/.
St James, S 2021, ‘Current Status of Radiopharmaceutical Therapy’, International journal of radiation oncology, biology, physics, vol. 109, viewed 30 July 2022, https://pubmed.ncbi.nlm.nih.gov/32805300/.
Strosberg, J 2017, ‘Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors’, The New England Journal of Medicine, viewed 1 August 2022, https://www.nejm.org/doi/full/10.1056/nejmoa1607427.
Wahl, R 2021, ‘Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy’, Journal of Nuclear Medicine, vol. 62, viewed 30 July 2022, https://jnm.snmjournals.org/content/62/1/6.
Recommended reading
